An unusual inflammatory response to implanted deep brain electrodes

Canadian Journal of Neurological Sciences

Volumn 38, Issue 1, 2011, Pages 168-170

  Hughes, Peter S ^a   Krcek, Jerry P ^a   Hobson, Douglas E ^a   Del Bigio, Marc R ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CD20 ANTIGEN; GABAPENTIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HLA DR ANTIGEN; IRIDIUM; LEVODOPA; LORAZEPAM; PLATINUM; PROPRANOLOL; TOPIRAMATE; URETHAN; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CASE REPORT; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DYSARTHRIA; DYSTONIA; HEART MUSCLE FIBROSIS; HUMAN; INFLAMMATION; MALE; MYOCARDITIS; PRIORITY JOURNAL; TREMOR; ELECTRODE; ENCEPHALITIS; METABOLISM; METHODOLOGY; MIDDLE AGED;

ANTIGENS, CD; DEEP BRAIN STIMULATION; ELECTRODES, IMPLANTED; ENCEPHALITIS; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MIDDLE AGED; TREMOR;

EID: 79952276230     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0317167100120840     Document Type: Article

References (35)

1. Umemura A, Jaggi JL, Hurtig HI, et al. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg. 2003;98(4):779-84. (Pubitemid 36396779)
2. Awan NR, Lozano A, Hamani C. Deep brain stimulation: current and future perspectives. Neurosurg Focus. 2009;27(1):E2.
3. Volkmann J. Deep brain stimulation for Parkinson's disease. Parkinsonism Relat Disord. 2007;13 Suppl 3:S462-5. (Pubitemid 351215287)
4. van Kuyck K, Welkenhuysen M, Arckens L, Sciot R, Nuttin B. Histological alterations induced by electrode implantation and electrical stimulation in the human brain: a review. Neuromodulation. 2007;10:244-61 (Pubitemid 46985585)
5. Anonymous. DBS lead kit for deep brain stimulation 3387/3389-implant manual. Minneapolis MN: Medtronic; 2008.
6. Sacher E. A re-examination of the polyurethane reaction. J Macromolecular Sci B. 1979;16(4):525-38.
7. Davies MJ. The investigation of sudden cardiac death. Histopathology. 1999;34(2):93-8. (Pubitemid 29083208)
8. Volkmann J. Deep brain stimulation for the treatment of Parkinson's disease. J Clin Neurophysiol. 2004;21(1):6-17. (Pubitemid 38507109)
9. Voges J, Hilker R, Botzel K, et al. Thirty days complication rate following surgery performed for deep-brain-stimulation. Mov Disord. 2007;22(10):1486-9. (Pubitemid 47280638)
10. Bhatia S, Oh M, Whiting T, Quigley M, Whiting D. Surgical complications of deep brain stimulation. A longitudinal single surgeon, single institution study. Stereotact Funct Neurosurg. 2008;86(6):367-72.
11. Deuschl G, Herzog J, Kleiner-Fisman G, et al. Deep brain stimulation: postoperative issues. Mov Disord. 2006;21 Suppl 14:S219-37. (Pubitemid 44028283)
12. Polikov VS, Tresco PA, Reichert WM. Response of brain tissue to chronically implanted neural electrodes. J Neurosci Methods. 2005;148(1):1-18. (Pubitemid 41423453)
13. Griffith RW, Humphrey DR. Long-term gliosis around chronically implanted platinum electrodes in the Rhesus macaque motor cortex. Neurosci Lett. 2006;406(1-2):81-6. (Pubitemid 44278374)
14. Biran R, Martin DC, Tresco PA. Neuronal cell loss accompanies the brain tissue response to chronically implanted silicon microelectrode arrays. Exp Neurol. 2005;195(1):115-26. (Pubitemid 41116819)
15. Dauth GW, Defendini R, Gilman S, Tennyson VM, Kremzner L. Long-term surface stimulation of the cerebellum in the monkey. I. Light microscopic, electrophysiologic, and clinical observations. Surg Neurol. 1977;7(6):377-84. (Pubitemid 8120358)
16. MeissnerW, Gross CE, Harnack D, Bioulac B, Benazzouz A. Deep brain stimulation for Parkinson's disease: potential risk of tissue damage associated with external stimulation-erratum. Ann Neurol. 2004;56(2):309-10.
17. Harnack D, Winter C, Meissner W, Reum T, Kupsch A, Morgenstern R. The effects of electrode material, charge density and stimulation duration on the safety of high-frequency stimulation of the subthalamic nucleus in rats. J Neurosci Methods. 2004;138(1-2):207-16. (Pubitemid 39485992)
18. Haberler C, Alesch F, Mazal PR, et al. No tissue damage by chronic deep brain stimulation in Parkinson's disease. Ann Neurol. 2000; 48(3):372-6.
19. McClelland S, 3rd, Vonsattel JP, Garcia RE, et al. Relationship of clinical efficacy to postmortem-determined anatomic subthalamic stimulation in Parkinson syndrome. Clin Neuropathol. 2007;26(6):267-75. (Pubitemid 350190316)
20. Guehl D, Vital A, Cuny E, et al. Postmortem proof of effectiveness of zona incerta stimulation in Parkinson disease. Neurology. 2008;70(16 Pt 2):1489-90. (Pubitemid 351521944)
21. Ghika J, Villemure JG, Miklossy J, et al. Postanoxic generalized dystonia improved by bilateral Voa thalamic deep brain stimulation. Neurology. 2002;58(2):311-3. (Pubitemid 34084229)
22. Patel NK, Heywood P, O'Sullivan K, McCarter R, Love S, Gill SS. Unilateral subthalamotomy in the treatment of Parkinson's disease. Brain. 2003;126:1136-45. (Pubitemid 36522956)
23. Talmant V, Esposito P, Stilhart B, Mohr M, Tranchant C. Stimulation des noyaux sous-thalamiques dans l'atrophie multisystematisee: a propos d'un cas anatomo-clinique. Rev Neurol (Paris). 2006;162(3):363-70.
24. Sun DA, Yu H, Spooner J, et al. Postmortem analysis following 71 months of deep brain stimulation of the subthalamic nucleus for Parkinson disease. J Neurosurg. 2008;109(2):325-9.
25. Pilitsis JG, Chu Y, Kordower J, Bergen DC, Cochran EJ, Bakay RA. Postmortem study of deep brain stimulation of the anterior thalamus: case report. Neurosurgery. 2008;62(2):E530-2; discussion E2. (Pubitemid 351489310)
26. Nielsen MS, Bjarkam CR, Sorensen JC, Bojsen-Moller M, Sunde NA, Ostergaard K. Chronic subthalamic high-frequency deep brain stimulation in Parkinson's disease-a histopathological study. Eur J Neurol. 2007;14(2):132-8. (Pubitemid 46151646)
27. Boockvar JA, Telfeian A, Baltuch GH, et al. Long-term deep brain stimulation in a patient with essential tremor: clinical response and postmortem correlation with stimulator termination sites in ventral thalamus. Case report. J Neurosurg. 2000;93(1):140-4. (Pubitemid 30457337)
28. Burbaud P, Vital A, Rougier A, et al. Minimal tissue damage after stimulation of the motor thalamus in a case of choreaacanthocytosis. Neurology. 2002;59(12):1982-4. (Pubitemid 36076578)
29. Jarraya B, Bonnet AM, Duyckaerts C, et al. Parkinson's disease, subthalamic stimulation, and selection of candidates: a pathological study. Mov Disord. 2003;18(12):1517-20. (Pubitemid 38035375)
30. Moss J, Ryder T, Aziz TZ, Graeber MB, Bain PG. Electron microscopy of tissue adherent to explanted electrodes in dystonia and Parkinson's disease. Brain. 2004;127(Pt 12):2755-63. (Pubitemid 39627383)
31. Guess WL, Haberman S. Toxicity profiles of vinyl and polyolefinic plastics and their additives. J Biomed Mater Res. 1968;2(3): 313-35.
32. Piver WT. Organotin compounds: industrial applications and biological investigation. Environ Health Perspect. 1973;4:61-79.
33. Alam MS, Husain R, Srivastava SP, Seth PK. Influence of dibutyltin dilaurate on brain neurotransmitter systems and behavior in rats. Arch Toxicol. 1988;61(5):373-7.
34. Lemperle G, Gauthier-Hazan N, Wolters M, Eisemann-Klein M, Zimmermann U, Duffy DM. Foreign body granulomas after all injectable dermal fillers: part 1. Possible causes. Plast Reconstr Surg. 2009;123(6):1842-63.
35. Anonymous. Enterovirus surveillance-United States 2002-2004. MMWR Morb Mortal Wkly Rep. 2006 55(6) 153-6.